FNC
NBRV

First National Corp’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

First National Corp’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4
Closed -$941K – 158
2020
Q1 		$941K Buy
+4
New +$1.22K 0.61% 38

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return

First National Corp's NBRV Position: Q2 2020 in Review

First National Corp sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q2 2020, closing a stake of 4 shares — an estimated $941K sold.

First National Corp first reported a position in NBRV in Q1 2020 and held it in 1 quarter. The position peaked at $941K in Q1 2020. 53 funds tracked by Wall St. Rank hold NBRV as of Q2 2020.

  • First National Corp reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q2 2020 after selling out during the quarter.
  • First National Corp sold 4 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q2 2020, an estimated $941K.
  • First National Corp first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q1 2020 and held it in 1 quarter.
  • First National Corp's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $941K in Q1 2020.
  • 53 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q2 2020.

Based on First National Corp's 13F filing for Q2 2020, filed 21 Jul 2020.